Serum Ferritin In CKD Patients Serum Ferritin
Sponsor
Assiut University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05947552
Collaborator
(none)
55
1
18.2
3
Study Details
Study Description
Brief Summary
Variability of serum ferritin in CKD patients and how these variables may affect the treatment decisions with iron supplements
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Serum ferritin has a wide range Variability in CKD patients this makes the use of serum ferritin as an indicator of iron deficiency is limited and mostly CKD is secondary to inflammation so serum ferritin as ferritin is an acute phase reactants so it will be very high in CKD patients ,
Study Design
Study Type:
Observational
Anticipated Enrollment
:
55 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Variability of Serum Ferritin in CKD Patients and How These Variables May Affect the Treatment Decisions With Iron
Anticipated Study Start Date
:
Jul 8, 2023
Anticipated Primary Completion Date
:
Jan 11, 2025
Anticipated Study Completion Date
:
Jan 11, 2025
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Chronic kidney disease Patients Chronic kidney Disease Patients stage 3 to stage 5 |
Drug: Serum ferritin
Serum ferritin in CKD patients
|
Outcome Measures
Primary Outcome Measures
- to assess the role of serum ferritin in CKD patients din in CKD patients and how these variability [Recurring]
affect treatment decisions with iron
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 50 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- ALL CKD patients stage 3 to 5 not on dialysis
Exclusion Criteria:
- inflammatory chronic diseases IDA Autoimmune disorders Liver diseases Malignancy Infections
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Assiut university | Assiut | Egypt |
Sponsors and Collaborators
- Assiut University
Investigators
- Study Director: Hawaid Ab Nafady, Professor, Assiut University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Reham Mahmoud Osman,
Assiut Lecturer,
Assiut University
ClinicalTrials.gov Identifier:
NCT05947552
Other Study ID Numbers:
- Serum Ferritin in CKD patients
First Posted:
Jul 17, 2023
Last Update Posted:
Jul 17, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms: